Drugs / EDS01
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07625423 | Mar 2026 → Mar 2028 expected | nasopharyngeal carcinoma | West China Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EDS01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07625423 ↗ |
| Action | Inhibit | “inhibit tumor angiogenesis” NCT07625423 ↗ |
| Route | Other | “administered by intratumoral injection” NCT07625423 ↗ |